REFERENCES
- McDonald G B, Sharma P. Venoocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors. Hepatology 1984; 4: 116–122
- Green D M, Finklestein J Z, Norkool P. Severe hepatic toxicity after treatment with single-dose dactinomycin and vincristine. Cancer 1988; 62: 270–273
- Green D M, Norkool P, Breslow N E. Severe hepatic toxicity after treatment with vincristine and dactinomycin using single-dose or divided-dose schedules: a report from the National Wilms’ Tumor Study. J Clin Oncol 1990; 8: 1525–1530
- Raine J, Bowman A, Wallendszus K. Hepatopathy-thrombocytopenia syndrome: a complication of dactinomycin therapy for Wilms’ tumor. A report from the United Kingdom Children's Cancer Study Group. J Clin Oncol 1991; 9: 268–273
- Ortega J A, Donaldson S S, Ivy S P. Venoocclusive disease of the liver after chemotherapy with vincristine, actinomycin d, and cyclophosphamide for the treatment of rhabdomyosarcoma: a report of the Intergroup Rhabdomyosarcoma Study Group. Cancer 1997; 79: 2435–2439
- Kanwar V S, Albuquerque MLC, Ribeiro R C. Veno-occlusive disease of the liver after chemotherapy for rhabdomyosarcoma: case report with a review of the literature. Med Pediatr Oncol 1995; 24: 334–340
- Bisogno G, de Kraker J, Weirich A. Veno-occlusive disease of the liver in children treated for Wilms’ tumor. Med Pediatr Oncol 1997; 29: 245–251
- Ludwig R, Weirich A, Abel U. Hepatotoxicity in patients treated according to the nephroblastoma trial and study SIOP-9/GPOH. Med Pediatr Oncol 1999; 33: 462–469
- Tornosella A, Piciacchia D, Mastrangelo S, Lasorella A, Mastrangelo R. Veno-occlusive disease of the liver in right-sided Wilms' tumours. Eur J Cancer 1998; 34: 1220–1223 [review]
- Ludwig R, Weirich A, Hofmann W J, Waldherr R. Veno-occlusive-disease (VOD) as hepatotoxic side eVect of the nephroblastoma SIOP-9 treatment protocol: preliminary results of the German Group. SIOP XXIV Meeting. Med Pediatr Oncol 1992; 20: 434 (abstract P170)
- Arndt C, Hawkins D, Anderson JR, Breitfelt P, Womer R, Meyer W. Age is a risk factor for chemotherapy-induced hepatopathy with vincristine, dactinomycin, and cyclophosphamide. J Clin Oncol 2004; 22: 1894–1901
- Adachi N, Matsuda I. Veno-occlusive disease of the liver after combined adjuvant chemotherapy for a 1-year-old boy with rhabdomyosarcoma: potential usefulness of gabexate mesylate (FOY). J Pediatr Gastroenterol Nutr 1992; 14: 314–318
- D’Antiga L, Pritchard J, Pryor D, Mieli-Vergani G. Veno-occlusive disease with multi-organ involvement following actinomycin-D. Eur J Cancer 2001; 37: 1141–1148
- Sulis M L, Bessmertny O, Granowetter L, Weiner M, Kelly K M. Veno-occlusive disease in pediatric patients receiving actinomycin D and vincristine only for the treatment of rhabdomyosarcoma. J Pediatr Hematol Oncol 2004; 26: 843–846
- Antman K, Eder J P, Elias A. High-dose alkylating agent preparative regimen with autologous bone marrow support: the Dana-Farber Cancer Institute/Beth Israel Hospital experience. Cancer Treat Rep 1987; 71: 119–125
- Jones R J, Lee K S, Beschorner W E. Venoocclusive disease of the liver following bone marrow transplantation. Transplantation 1987; 44: 778–783
- Rechner I, Brito-Babapulle F, Fielden J. Systemic capillary leak syndrome after granulocyte colony-stimulating factor (G-CSF). Hematol J 2003; 4: 54–56
- Dagdemir A, Albayrak D, Dilber C, Totan M. G-CSF related capillary leak syndrome in a child with leukemia. Leuk Lymphoma 2001; 42: 1445–1447
- Spitzer TR. Engraftment syndrome following hematopoietic stem cell transplantation. Bone Marrow Transplant 2001; 27: 893–898
- Teelucksingh S, Padfield P L, Edwards C R. Systemic capillary leak syndrome. Q J Med 1990; 75: 515–524
- Helmy A. Review article: updates in the pathogenesis and therapy of hepatic sinusoidal obstruction syndrome. Aliment Pharmacol Ther 2006; 23: 11–25